Member Info for Fastfood

I think the Cards we do hold Techt (other than the Patented Technology) are with regard to the Sales to rest of the World. Bio and the unnamed HNWI just won’t bypass the opportunity for themselves to miss out on a piece of the rest of the World potential.

Quickly / one can see that it’s complicated re Agreement but one hopes that Relationships are being formed and that parties can work together to achieve success. And then Repeat success with whatever else we have in the locker.

Or excuse the pun / it will all fall down like a pack of cards.

You’d think these HNWI would be chipping away at 1.6p but appears not ??

Ohh good. Every penny it goes up I make £80.

“Further work” is to say the least a broad spectrum and could result in nothing to substantial. I just don’t think it will play out re “We’ve identified an improvement so here’s the money”.

Bio is more of a vehicle / a shell imo purely designed to ring fence Investment vs Risk and then control Reward. This being a more efficient way to get to Market. Relationships are vital and you couldn’t wish for much better here with Corepath and now Bill.

My concern is that as Techt says / we may have to concede too much at each stage of Progress if it gets to a binding Contract (which both Parties want) ie : The MoU already concedes Reward if the Test is successful vs the 10 or 15% on Sales previously Agreed. Now it’s $1m every 15 month. So evidence already that ground has been conceded.

Still I would be happy if it gets to completion because some 400 million humans in USA and Canada and IF the Test becomes integral to Lung Cancer Screening / then there’s some 8 Billion humans left / only then we would have a proven concept.

So you would think that Bio would want a Share of the rest of the World and rightly so. But this could provide Cizz with wriggle room on our side of the Negotiating Table..

Still be nice to know the $100k in the Bank. Coming up on 6 weeks now..

Neil / my point being is can we get to a place where Dilution ends. Or at the very least where by any future Share Raise becomes accretive - which in itself is always subjective. So I shall go for the former. Can we get to a place where Dilution ends ? Certainly the BoD have always looked to minimise this imo.

$300 not $309. Typo.

Thank you for input Neil. Hopefully I am wrong but the RNS is worded such that there is an element of doubt and this can be remedied only by Notification that $100k in the bank of Ciz. Hopefully it is as we speak !!

Re the $100k I expect this will merely cover our own Legal Fees if Binding Agreement occurs.

Re the $309k and then $1m every 15th anniversary / Neil would you expect this to cover our current cash burn ? Yes ? Allow room to accelerate some development on other Cancers ??

If I am wrong that would be most welcome.

At no point does Bill state “We have entered”, like Allan does. So I read is though it’s an exciting opportunity and it’s on the table. Nothing more.

Tell me I’m wrong..

Allan Syms, Executive Chairman of Cizzle Biotechnology, said:

"We are delighted to have entered into this Memorandum of Understanding to create an independently financed and locally managed company that can build a business to serve the North American market. Apart from securing important guaranteed minimum and ongoing licensing revenue and free equity participation for the Company, there will be a significant reduction on planned costs associated with clinical trials and product accreditation. This represents a substantial opportunity to expand the Company's presence in North America through securing non-dilutive major investment and in building a high value dedicated US based leadership team to establish operations and drive adoption in this important market."

Bill Behnke, CEO of BIO, commented:

"Lung cancer is the leading cause of cancer deaths in the USA because of the unmet need for a simple blood test to aid physicians in the early detection of cancer. Through a strong appreciation of the potential value of the CIZ1B biomarker in improving patient survival rates we are very excited by the opportunity to secure an exclusive license from Cizzle for the North American market. Our investor group sees this as an important opportunity to make a major difference to lung cancer survival rates and we have already made progress in developing further relationships with major cancer hospitals as we seek endorsement from clinicians and key opinion leaders."

The MoU is on the table. Ciz have signed. No confirmation Bio have signed yet - Until they say Bio have signed. Only way to know if they have is if it is RNS’d as such or indeed Ciz confirm $100k received. Neither of which has occured yet imo.

Yes - While ever the MoU is on the table it is an “Opportunity to secure X”. But if it remains on the table but unsigned by Bio / then that’s all it is. “An Opportunity”. At no point does the RNS confirm that Bio signed it. It confirms we signed it. Correct me if I’m wrong / but the MoU remains on the table until Ciz remove it and so remains the Opportunity for Bio to sign.

The Question is Are we currently in a Fixed 120 day Negotiation period ?

The only way to Clarify if we are is to gain confirmation that the $100k has been received as this is the kicker to Activate the 120 days Exclusivity Negotiation Petiod.

In the RNS its states we have signed the MoU.

At no point in RNS does it state BIO signed the MoU.

It reads to me that there is a MoU. We have entered into it. There is NO CONFIRMATION that Bio have entered into it thus Activating that 30 day period to pay the $100k.

Read Bill Benkhe’s comments. He says they are happy for the “Opportunity”. He doesn’t confirm they have signed yet like we did.

It’s a logical Question. Have Bio entered into this MoU and signed to activate the initial 30 days and paid the $100k or not ?

And there is no doubt there is a MOU Jace. Because we have signed it. The Issue is have Bio signed it ? as then and only then is when the 30 days non refundable window opens for us to receive the $100k.

For all we know we are still waiting for that window to open / ie : The initial 30 days…

This is not good.

That’s exactly the issue here Jace. We shouldn’t have to ”Think” / to Question if Negotiations are now Active. It doesn’t say Bio have signed the MOU. It says we have. The 30 days to receive the $100k only start when Bio also signed. So let’s have confirmation where we are at shall we ?

I am hoping that it’s just poor comms and that Bio signed same time as us but that’s not what the RNS says does it ??

You’d think if we had received the $100k that Allan would at least put something on LinkedIn ??

You’re right Bermondsey. So have Bio even signed the MOU ?????

Oh dear Oh dear….. Allan Strikes again. I agree with you now Bermondsey.

RNS clearly states he following..

“BIO is paying a non-refundable upfront fee of US$100,000 within 30 days of signing the MoU”.

Bermondsey. If we haven’t had $100k then Allan has to notify the Market. Or again it’s very poor and misleading comms.

“Cizzle will receive an up-front payment of US$100,000 within 30 days as a non-refundable fee to grant BIO an exclusive negotiating period of 120 days”.

WILL Receive.. So if we have not received then that would render 2nd April RNS untrue and thus a follow up RNS Notification would be required to remedy that one. So we must have the $100k as it stands.

All Shareholders welcome no matter the size.

At least we know that we have received the $100k because if we haven’t then AS is now telling Porkies by his lack of notification of receipt and according to the wording of RNS 2nd April.

I hear you JB. I hear you.

Wasn’t having a go about the 6 month. I think re Alan Miller and who he is / I would seriously doubt that he is in the dark like us lol.